About Donald R. Marvin

Serial Entrepreneur and Company Builder – Operator with Four Successful Exits

Donald R. Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences, agri-food and research products for more than 35 years. He served as the Executive Vice President and Chief Financial Officer of Lodo Therapeutics Corporation, a drug discovery company developing novel cancer and anti-infective therapeutics until its acquisition by a major biotech company. After five years as President and CEO, Mr. Marvin became Chairman of Concentric, an agtech company that develops biological and essential plant nutrient inputs for specialty and broadacre crops. Prior to Concentric, Mr. Marvin was Managing Partner of Cairn Associates, a biotechnology, life science and consumer products strategy and financial advisory firm. Earlier, he was President and CEO of IdentiGEN, a leading provider of DNA-based solutions to the agriculture and food industries. Mr. Marvin was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as Chief Operating Officer, Chief Financial Officer and Senior Vice President of Corporate Development. Previously, Mr. Marvin was President and CEO of Diatron Corporation, a developer of fluorescence-based clinical diagnostics instruments.

His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.

Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey’s CFO of the year, he has raised over $400 million in both private and public financings and completed over a dozen successful mergers and acquisitions transactions for his former companies. He has served on the boards of several public and privately held companies and regularly contributes columns about agri-food developments and impact to Forbes Media.

He earned a Bachelor of Science in Microbiology from Ohio State University and a Master of Business Administration in Organizational Behavior and Finance from Iona College.